APOE and Parkinson disease: In two studies using the Parkinson’s Progression Marker initiative (PPMI) cohort, a lower baseline lymphocyte count was associated with cognitive decline in PD patients with the apolipoprotein E ε4 allele [21] and motor deterioration [22], suggesting that lymphocyte reduction has potential predictive power for outcome in PD patients.